A Gowanus farmer’s writings from 1828 to 1830 describe burying them on property that includes the proposed site of a prekindergarten.
NYS Entity Status
NYS Filing Date
JANUARY 17, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - LAUREL B PROPERTIES, INC.
Around the Web
- 19th-Century Diary Suggests Slaves Are Buried in Brooklyn Lot
By MICHAEL WILSON - Friday Aug 4, 2017
- A High School Without Textbooks
Tuesday Oct 8, 2013
Archbishop Stepinac High School, in White Plains, N.Y., is one of the first schools in the U.S. to do away with paper textbooks. Instead, the all-boys prep school requires students to use tablets and laptops in class. (Data provided by Statista.com.)
- Hamptons Property Asks $150 Million
Thursday Jul 13, 2017
The 14-acre beachfront spread on Meadow Lane in Southampton, N.Y., was assembled from four parcels of land and includes several homes.
- Bill and Hillary Clinton's Hamptons Summer Rental Sells
Tuesday Aug 29, 2017
In East Hampton, N.Y., the property was sold by real estate developer Elie Hirschfeld, president of Hirschfeld Properties.
- California wildfires: Michael Dornbach, who loved visiting Napa hills, dies
By Erin Allday - Monday Oct 16, 2017
Michael Dornbach loved the rugged, rolling hills of northern Napa County — the quiet, the isolation, and the way the stars shone bright at night, piercing the sky between the dark cover of oak and laurel trees. He loved his nephew too, and his sister and other friends and family who lived in and around Calistoga. He was visiting from Southern California last week, thinking about buying a small piece of property of his own, when the fires roared to life. Mr. Dornbach, 57, wasn’t able to escape. He died early Monday in the Tubbs Fire that started west of Calistoga.
- Cancer drug research moving fast in immunotherapy field
By Michelle Fay Cortez - Tuesday Sep 5, 2017
The last few weeks have been historic in the fight against cancer. Novartis got approval for the first treatment in a revolutionary new class of drugs, shortly after Gilead Sciences Inc. spent $11.9 billion on a biotech company working in the field. Neither can rest on its laurels. Research in the field is moving so fast that today’s breakthroughs can easily become tomorrow’s has-beens. “I can’t think of any other therapies in oncology that have seen such rapid development,” said Rachel Webster, senior director of oncology at Decision Resources Group, a health care research and consulting firm in London.